Showing all 5 results
Naproxen Sodium Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Burst Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or high-density PVC/PVDC blister strips to ensure the absolute chemical stability of the hygroscopic sodium salt.
Active Ingredient Strength Primary Clinical Function Naproxen Sodium USP/Ph.Eur. 275 mg
(Equivalent to 250 mg Naproxen base)Acute Mild / OTC Standard: Base therapeutic unit for rapid relief of tension headaches, mild trauma, and OTC fever reduction. Naproxen Sodium USP/Ph.Eur. 550 mg
(Equivalent to 500 mg Naproxen base)Acute Severe Rx Standard: High-dose “loading” therapy to instantly abort severe acute migraines, acute gout flares, and post-surgical pain. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K30 / Talc / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder / Moisture-Barrier Coating (Engineered specifically to protect the hygroscopic salt from humidity in the blister, but trigger a violent, immediate structural collapse the exact second it hits the stomach) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for high-turnover acute dispensing and retail pharmacy OTC placement).
Naproxen Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Enteric-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active ingredient and the protective polymer matrix.
Active Ingredient Strength Primary Clinical Function Naproxen USP/Ph.Eur. 250 mg (EC) Initiation / Mild Standard: Base therapeutic unit for mild musculoskeletal trauma, acute gout, and primary dysmenorrhea. Naproxen USP/Ph.Eur. 500 mg (EC) Global Rheumatology Standard: High-dose adult maintenance therapy for severe Rheumatoid Arthritis, Osteoarthritis, and Ankylosing Spondylitis. Excipients Methacrylic Acid Copolymer / Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K30 / Triethyl Citrate / Magnesium Stearate pH-Dependent Enteric Barrier / Diluent / Superdisintegrant / Plasticizer (Engineered specifically to absolutely block dissolution in the highly acidic stomach, preventing mucosal burns, and rapidly dissolving only in the alkaline duodenum) *Pack Sizes: 10×10 Blisters or Bottles of 100/500 (Optimized specifically for strict chronic orthopedic dispensing regimens and massive government health tenders).
Nimesulide ,Paracetamol & Chlorzoxazone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Burst Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of all three active ingredients.
Active Ingredient Strength Primary Clinical Function Nimesulide BP/Ph.Eur. 100 mg Preferential COX-2 NSAID: Rapid abortion of localized musculoskeletal inflammation and tissue swelling. Paracetamol (Acetaminophen) BP/Ph.Eur. 325 mg Central Analgesic: Synergistic pain threshold elevation and antipyretic control. Chlorzoxazone USP/Ph.Eur. 250 mg Central Muscle Relaxant: Direct inhibition of spinal reflex arcs to break severe, locked muscle spasms. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K30 / Magnesium Stearate / Premium Opadry Film Diluent / Superdisintegrant / Binder / Moisture-Barrier Coating (Engineered specifically to trigger a violent, immediate structural collapse in the stomach, ensuring all three APIs are absorbed simultaneously for synchronized relief) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, short-term acute dispensing to ensure patients do not exceed the mandated 15-day Nimesulide therapy limit).
Nimesulide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Rapid-Burst Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the active ingredient.
Active Ingredient Strength Primary Clinical Function Nimesulide BP/Ph.Eur. 100 mg Global Acute Standard: High-efficacy adult therapeutic unit for the rapid, short-term abortion of acute inflammatory pain. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Docusate Sodium / Povidone K30 / Magnesium Stearate Diluent / Superdisintegrant / Wetting Surfactant / Binder (Engineered specifically to trigger a violent, immediate structural collapse in the stomach, maximizing the drug’s surface area for ultra-fast gastrointestinal absorption) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, short-term acute dispensing to ensure patients do not exceed the mandated 15-day therapy limit).
Nimesulide,Paracetamol & Serratiopeptidase Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Multi-Particulate Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the highly delicate enzyme component.
Active Ingredient Strength Primary Clinical Function Nimesulide BP/Ph.Eur. 100 mg Preferential COX-2 NSAID: Rapid abortion of localized musculoskeletal inflammation and tissue pain. Paracetamol (Acetaminophen) BP/Ph.Eur. 325 mg Central Analgesic: Synergistic pain threshold elevation and antipyretic control. Serratiopeptidase (as Enteric-Coated Granules) 15 mg
(Equivalent to 30,000 Serratiopeptidase Units)Proteolytic Enzyme: Direct breakdown of fibrin and inflammatory exudate to physically drain severe localized edema. Excipients Methacrylic Acid Copolymer / Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K30 / Magnesium Stearate Enteric Polymer Shield / Diluent / Superdisintegrant / Binder (Engineered specifically to protect the enzyme from gastric acid while allowing the analgesics to dissolve instantly in the stomach) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, short-term acute dispensing to ensure patients do not exceed the mandated 15-day Nimesulide therapy limit).
